Clinical trial
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive…
NCT00002354 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00002354 |
|---|---|
| Title | A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients |
| Official title | One Year Study in HIV-1 Seropositive, AZT-Experienced Patients to Evaluate the Safety and Efficacy of MK-639 Administered Concomitantly With Stavudine (d4T) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir sulfate, Stavudine |
| Enrollment | 540 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: